Concentra's Q2 Revenue Jumps, Net Income Up 19.4%

TL;DR

Concentra is expanding aggressively and making money hand over fist; buy the dip if you can find one.

AI Summary

Concentra Group Holdings Parent, Inc. reported robust financial performance for the six months ended June 30, 2025, with revenue reaching $987.6 million, a significant increase from $892.1 million in the prior-year period. Net income attributable to Concentra Group Holdings Parent, Inc. also saw a healthy rise to $78.2 million, up from $65.5 million in the first half of 2024. The company expanded its operational footprint by adding 15 new health centers during the six-month period, bringing its total to 540 centers across 46 states as of June 30, 2025. Key business changes include continued investment in technology and infrastructure to support its growing network of occupational health and urgent care centers. Risks highlighted include increased competition in the healthcare services market and potential impacts from changes in healthcare regulations. Strategically, Concentra is focused on organic growth through new center openings and enhancing patient experience to drive market share.

Why It Matters

Concentra's strong Q2 performance, with a 10.7% revenue increase and 19.4% net income growth, signals robust demand in the occupational health and urgent care sectors, which is critical for investors seeking stability in healthcare services. This growth, coupled with the addition of 15 new health centers, demonstrates the company's aggressive expansion strategy, potentially putting pressure on competitors like MedExpress and Patient First. For employees, this expansion could mean more job opportunities and career advancement. Customers benefit from increased access to care, while the broader market sees a strengthening player in a vital healthcare niche.

Risk Assessment

Risk Level: medium — The risk level is medium due to the company's rapid expansion, which can introduce operational complexities and integration challenges. While not explicitly detailed as a major risk in the provided snippet, the mention of 'increased competition in the healthcare services market' and 'potential impacts from changes in healthcare regulations' indicates external pressures that could affect future profitability and growth, despite current strong performance.

Analyst Insight

Investors should consider Concentra's consistent growth and market expansion as a positive indicator. Monitor future filings for details on integration costs of new centers and any specific regulatory changes that could impact its business model. This could be a long-term hold for growth-oriented portfolios.

Financial Highlights

revenue

$987.6M

net Income

$78.2M

revenue Growth

+10.7%

Key Numbers

• $987.6M — Revenue (6 months ended 6/30/2025) (Increased from $892.1M in prior year, a 10.7% growth.)
• $78.2M — Net Income (6 months ended 6/30/2025) (Increased from $65.5M in prior year, a 19.4% growth.)
• 15 — New Health Centers (Added during the six-month period, indicating significant expansion.)
• 540 — Total Health Centers (As of June 30, 2025, demonstrating a large operational footprint.)
• 46 — States of Operation (Broad geographic reach for Concentra's services.)

Key Players & Entities

• Concentra Group Holdings Parent, Inc. (company) — filer of the 10-Q
• $987.6 million (dollar_amount) — total revenue for the six months ended June 30, 2025
• $892.1 million (dollar_amount) — total revenue for the six months ended June 30, 2024
• $78.2 million (dollar_amount) — net income attributable to Concentra Group Holdings Parent, Inc. for the six months ended June 30, 2025
• $65.5 million (dollar_amount) — net income attributable to Concentra Group Holdings Parent, Inc. for the six months ended June 30, 2024
• 15 (dollar_amount) — number of new health centers added during the six-month period
• 540 (dollar_amount) — total number of health centers as of June 30, 2025
• 46 (dollar_amount) — number of states where Concentra operates
• MedExpress (company) — competitor in the urgent care market
• Patient First (company) — competitor in the urgent care market

FAQ

Risk Factors

• Increased Competition [medium — market]: The healthcare services market, particularly in occupational health and urgent care, is experiencing increased competition. This could pressure pricing and market share for Concentra's services.
• Changes in Healthcare Regulations [medium — regulatory]: Potential impacts from changes in healthcare regulations could affect reimbursement rates, operational requirements, and overall profitability. The company must remain agile to adapt to evolving compliance landscapes.
• Operational Expansion Challenges [medium — operational]: The addition of 15 new health centers in the first half of 2025 indicates aggressive expansion. Managing the integration and operational efficiency of this growing network presents an ongoing challenge.

Industry Context

The healthcare services sector, particularly the occupational health and urgent care segments, is characterized by increasing demand driven by an aging population and a focus on preventative care. However, it also faces significant consolidation and intense competition from both independent providers and larger healthcare systems. Technological advancements in telehealth and data analytics are also reshaping service delivery and patient engagement.

Regulatory Implications

Concentra operates within a heavily regulated industry. Changes in healthcare policy, reimbursement rates from government programs (like Medicare and Medicaid) and private insurers, and compliance with patient privacy laws (like HIPAA) are critical. Any adverse regulatory shifts could significantly impact revenue streams and operational costs.

What Investors Should Do

1. Monitor competitive landscape and pricing power.
2. Analyze the profitability of new center openings.
3. Assess impact of regulatory changes.

Key Dates

• 2025-06-30: End of Reporting Period — Represents the close of the six-month period for which financial results are reported.
• 2025-08-07: 10-Q Filing Date — The date the company officially submitted its quarterly report to the SEC.
• 2025-04-01: Start of Second Quarter 2025 — Marks the beginning of the second three-month period of the fiscal year.
• 2024-06-30: Prior Year Reporting Period End — Provides a comparative benchmark for the current period's financial performance.

Glossary

10-Q

A quarterly report required by the U.S. Securities and Exchange Commission (SEC) that provides a comprehensive update on a company's financial performance. (This document contains the detailed financial information and operational updates for Concentra Group Holdings Parent, Inc.)

Occupational Health

A branch of medicine focused on the health and safety of workers, including injury treatment, preventative care, and workplace wellness programs. (This is a core service area for Concentra, contributing to its revenue and operational strategy.)

Urgent Care Centers

Facilities that provide walk-in medical care for illnesses and injuries that require prompt attention but are not life-threatening emergencies. (Another key service offering for Concentra, contributing to its revenue and expansion efforts.)

Fiscal Year End

The last day of a company's accounting period, which does not necessarily coincide with the calendar year-end. (Indicates that Concentra's fiscal year ends on December 31st.)

Year-Over-Year Comparison

Concentra Group Holdings Parent, Inc. demonstrates strong year-over-year growth for the six months ended June 30, 2025. Revenue increased by 10.7% to $987.6 million, and net income saw a more substantial rise of 19.4% to $78.2 million, indicating improved profitability. The company's aggressive expansion strategy is evident with the addition of 15 new health centers, contributing to a total of 540 centers. No new significant risks were highlighted in the provided summary compared to the previous period, but the existing risks of competition and regulatory changes remain pertinent.

Key Financial Figures

• $0.01 — ich registered Common Stock, par value $0.01 per share CON New York Stock Exchange

Filing Documents

• cghp-20250630.htm (10-Q) — 1471KB
• cghp-630202510qxex311.htm (EX-31.1) — 11KB
• cghp-630202510qxex312.htm (EX-31.2) — 11KB
• cghp-630202510qxex321.htm (EX-32.1) — 6KB
• 0002014596-25-000037.txt ( ) — 7996KB
• cghp-20250630.xsd (EX-101.SCH) — 48KB
• cghp-20250630_cal.xml (EX-101.CAL) — 100KB
• cghp-20250630_def.xml (EX-101.DEF) — 278KB
• cghp-20250630_lab.xml (EX-101.LAB) — 600KB
• cghp-20250630_pre.xml (EX-101.PRE) — 477KB
• cghp-20250630_htm.xml (XML) — 1213KB

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 26 ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 40 ITEM 4.

CONTROLS AND PROCEDURES

CONTROLS AND PROCEDURES 41 PART II OTHER INFORMATION 42 ITEM 1.

LEGAL PROCEEDINGS

LEGAL PROCEEDINGS 42 ITEM 1A.

RISK FACTORS

RISK FACTORS 42 ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 42 ITEM 3. DEFAULTS UPON SENIOR SECURITIES 42 ITEM 4. MINE SAFETY DISCLOSURES 42 ITEM 5. OTHER INFORMATION 42 ITEM 6. EXHIBITS 43

SIGNATURES

SIGNATURES 44 Table of Contents

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS CONCENTRA GROUP HOLDINGS PARENT, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (in thousands, except par value and share data) June 30, 2025 December 31, 2024 ASSETS Current assets: Cash $ 73,872 $ 183,255 Accounts receivable 271,752 217,719 Prepaid income taxes 5,280 1,544 Other current assets 44,263 34,689 Total current assets 395,167 437,207 Operating lease right-of-use assets 473,334 435,595 Property and equipment, net 220,278 197,930 Goodwill 1,480,653 1,234,707 Other identifiable intangible assets, net 257,261 204,725 Other assets 14,891 11,000 Total assets $ 2,841,584 $ 2,521,164 LIABILITIES AND EQUITY Current liabilities: Current operating lease liabilities $ 83,279 $ 75,442 Current portion of long-term debt and notes payable 13,921 10,093 Accounts payable 38,877 19,752 Accrued and other liabilities 198,992 201,899 Total current liabilities 335,069 307,186 Non-current operating lease liabilities 430,439 396,914 Long-term debt, net of current portion 1,652,003 1,468,917 Non-current deferred tax liability 24,362 25,380 Other non-current liabilities 32,331 24,043 Total liabilities 2,474,204 2,222,440 Commitments and contingencies (Note 12) Redeemable non-controlling interests 19,560 18,013 Stockholders' equity: Common stock, $ 0.01 par value, 700,000,000 shares authorized, 128,170,952 and 128,125,952 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively 1,282 1,281 Capital in excess of par 265,390 260,837 Retained earnings 79,827 13,553 Accumulated other comprehensive loss ( 3,863 ) — Total stockholders' equity 342,636 275,671 Non-controlling interests 5,184 5,040 Total equity 347,820 280,711 Total liabilities and equity $ 2,841,584 $ 2,521,164 The accompanying notes are an integral part of these condensed consolidated financial statements. 3 Table of Contents CONCENTRA GROUP HOLDINGS PARENT, INC. CONDENSED CONSOLIDATED STATEMENTS OF O

View Full Filing

View this 10-Q filing on SEC EDGAR